Novo Nordisk will open a €135M Diabetes R&D Center at Oxford University
A new research center funded by Novo Nordisk will foster collaborations between its staff and…
A new research center funded by Novo Nordisk will foster collaborations between its staff and…
We had the opportunity to hear the story behind the successful Evotec by Thomas Hanke, Executive VP,…
The German CRO has struck a deal with the University of Oxford to test a…
A new transparency study has identified Sanofi, Novartis and GSK as the companies that keep the…
HIV has completely disappeared from the blood of a patient in clinical trials. The new HIV treatment that…
Researchers from the University of Oxford have discovered how certain neurons control when we go…
Immunocore has published key results for its new preclinical candidate for HIV, ImmTAV. This TCR-based…
Oxitec (UK) is on track to be allowed to trial their self-limiting, genetically engineered mosquitoes…
Choroideremia is a rare X-linked recessive retinal disease which eventually leads to blindness. A series…